Literature DB >> 12932875

An epidemiological survey of vulvovaginal candidiasis in Italy.

Salvatore Corsello1, Arsenio Spinillo, Giuseppe Osnengo, Carlo Penna, Secondo Guaschino, Anna Beltrame, Nicola Blasi, Antonio Festa.   

Abstract

Eight Italian hospital or University gynecology clinics participated in a prospective survey of patients with culture-confirmed symptomatic vulvovaginal candidiasis (VVC) (October 1999 to March 2001). Of 1138 patients recruited in the study, 931 were evaluable. A recent history of VVC was documented in 43.5% patients (358/823) with a mean number of 2.9+/-2.7 episodes per patient (N=302). A total of 77 patients (10.0%) had a history of recurrent VVC (four and more episodes in a 12-month period). The most frequent associated factors were related to life style: synthetic fabric underwear, vaginal douching and bike, training bike and motorbike (about 1/3 each). Oral contraception was found in 20.8% patients, recent antibiotic use in 15.9% patients, current pregnancy concerned 10.3% patients while 3.4% patients were taking hormonal replacement therapy. Diabetes, corticosteroids or HIV were rarely encountered. Yeast was documented by direct microscopy in 78.3% patients (448/572). A positive culture was obtained in 98.3% patients (909/925). Candida albicans was the predominant species (77.1%), followed by Candida glabrata (14.6%) and Candida krusei (4.0%). With the exception of one center with a lower proportion of C. albicans, this latter represented between 75 and 85% of the isolates. Overall, this study confirmed the preponderant role played by C. albicans in either sporadic and recurrent VVC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932875     DOI: 10.1016/s0301-2115(03)00096-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  30 in total

1.  A new model of vaginal infection by Candida albicans in rats.

Authors:  Márcia A Carrara; Lucélia Donatti; Edílson Damke; Terezinha I E Svidizinski; Márcia E L Consolaro; Márcia R Batista
Journal:  Mycopathologia       Date:  2010-06-09       Impact factor: 2.574

2.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 3.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  An estimate of the burden of serious fungal diseases in Greece.

Authors:  M N Gamaletsou; M Drogari-Apiranthitou; D W Denning; N V Sipsas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

5.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

Review 6.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital.

Authors:  Latha Ragunathan; G K Poongothai; Annie Rofeena Sinazer; Kavitha Kannaiyan; Hemalatha Gurumurthy; Nirmala Jaget; Sethumadhavan Kuthalaramalingam
Journal:  J Clin Diagn Res       Date:  2014-05-15

8.  Characterization of plant-derived saponin natural products against Candida albicans.

Authors:  Jeffrey J Coleman; Ikechukwu Okoli; George P Tegos; Edward B Holson; Florence F Wagner; Michael R Hamblin; Eleftherios Mylonakis
Journal:  ACS Chem Biol       Date:  2010-03-19       Impact factor: 5.100

9.  Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.

Authors:  Jana Tits; Freya Cools; Kaat De Cremer; Katrijn De Brucker; Judith Berman; Kristof Verbruggen; Bert Gevaert; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

10.  Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.

Authors:  Soledad Gamarra; Susana Morano; Catiana Dudiuk; Estefanía Mancilla; María Elena Nardin; Emilce de Los Angeles Méndez; Guillermo Garcia-Effron
Journal:  Mycopathologia       Date:  2014-07-09       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.